Development of management strategies for immune-related adverse effects of immunotherapies used in oncological treatment
Abhishek Shankar(DR. B.R.A. Institute Rotary Cancer Hospital), Tulika Seth(Manipal Academy of Higher Education), Sachidanand Jee Bharati(DR. B.R.A. Institute Rotary Cancer Hospital), Callum Yau(University of Sheffield), Pritanjali Singh(All India Institute of Medical Sciences), Seema Mishra(DR. B.R.A. Institute Rotary Cancer Hospital), Deepak Saini(Indian Cancer Society), Shubham Roy(Indian Cancer Society), Isaac George Wallbridge(University of Sheffield)
Cited by 6
Related Papers
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
Platelet activation determines the severity of thrombocytopenia in dengue infection
|Scientific Reports|2017|198
Autologous stem cell transplantation in refractory Asherman′s syndrome: A novel cell based therapy
|Journal of Human Reproductive Sciences|2014|184
Environmental and occupational determinants of lung cancer
|Translational Lung Cancer Research|2019|171
Recommendations for screening and early detection of common cancers in India
|The Lancet Oncology|2015|125